retatrutide triple agonist gip glp-1 glucagon phase 2 obesity Agonism Based Therapies for | Current Cardiovascular Risk Reports Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19























